Cite
HARVARD Citation
Sandborn, W. et al. (n.d.). Defining Remission Using Patient‐reported Outcome Components of the Crohn's Disease Activity Index: Post‐hoc Analyses of Vedolizumab Data from the GEMINI 2 Study. American journal of gastroenterology. p. . [Online].